Llinàs-Arias, Pere
Ensenyat-Méndez, Miquel
Orozco, Javier I. J.
Íñiguez-Muñoz, Sandra
Valdez, Betsy
Wang, Chuan
Mezger, Anja
Choi, Eunkyoung
Tran, Yan Zhou
Yao, Liqun
Bonath, Franziska
Olsen, Remi-André
Ormestad, Mattias
Esteller, Manel
Lupien, Mathieu
Marzese, Diego M.
Funding for this research was provided by:
Instituto de Salud Carlos III (CD22/00026, CPII22/00004)
Balearic Islands Health Research Institute (IMP21/10)
Govern de les Illes Balears, Spain (Margalida Comas, FPI)
Asociación Española Contra el Cancer (PhD student fellowship)
EASI-Genomics 3rd Call (EpiMeTN, EpiMeTN, EpiMeTN, EpiMeTN, EpiMeTN, EpiMeTN, EpiMeTN, EpiMeTN, EpiMeTN)
Article History
Received: 16 May 2023
Accepted: 19 October 2023
First Online: 2 November 2023
Declarations
:
: This study was approved by the Institutional Research Board of Hospital Universitario Son Espases (Code CI-542–21). It was performed following the Declaration of Helsinki. Written informed consent was obtained from each patient included by the original institutions.
: Not applicable.
: The authors declare no competing interests.